Vanguard Group’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10
| Closed | -$7.7K | – | 4440 |
|
|
2024
Q1 | $7.7K | Hold |
10
| – | – | ﹤0.01% | 4434 |
|
|
2023
Q4 | $9.47K | Hold |
10
| – | – | ﹤0.01% | 4480 |
|
|
2023
Q3 | $9.38K | Hold |
10
| – | – | ﹤0.01% | 4523 |
|
|
2023
Q2 | $22.3K | Sell |
10
-1
| -9% | -$2.29K | ﹤0.01% | 4511 |
|
|
2023
Q1 | $29.5K | Sell |
11
-15
| -58% | -$48.3K | ﹤0.01% | 4509 |
|
|
2022
Q4 | $58.4K | Sell |
26
-12
| -32% | -$42.6K | ﹤0.01% | 4430 |
|
|
2022
Q3 | $264K | Sell |
38
-6
| -14% | -$45.4K | ﹤0.01% | 4375 |
|
|
2022
Q2 | $333K | Hold |
44
| – | – | ﹤0.01% | 4380 |
|
|
2022
Q1 | $631K | Hold |
44
| – | – | ﹤0.01% | 4337 |
|
|
2021
Q4 | $785K | Hold |
44
| – | – | ﹤0.01% | 4332 |
|
|
2021
Q3 | $1.62M | Buy |
44
+1
| +2% | +$34.5K | ﹤0.01% | 4125 |
|
|
2021
Q2 | $1.64M | Buy |
43
+4
| +10% | +$178K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $2.1M | Buy |
39
+36
| +1,200% | +$2.06M | ﹤0.01% | 3850 |
|
|
2020
Q4 | $88K | Buy |
3
+2
| +200% | +$58.6K | ﹤0.01% | 4152 |
|
|
2020
Q3 | $32K | Buy |
+1
| New | +$39.6K | ﹤0.01% | 4085 |
|
|
2019
Q3 | – | Hold |
0
| – | -$66K | – | 4164 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4083 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4067 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4091 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4067 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3906 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3525 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3598 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3611 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3562 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3495 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3420 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3108 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3147 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3162 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3264 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3352 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3287 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3240 |
|
Other funds holding DCOY
AC
TRCT
Vanguard Group's DCOY Position: Q2 2024 in Review
Vanguard Group sold out of Decoy Therapeutics (DCOY) in Q2 2024, closing a stake of 10 shares — an estimated $7.7K sold.
Vanguard Group first reported a position in DCOY in Q3 2020 and held it in 15 quarters. The position peaked at $2.1M in Q1 2021. 3 funds tracked by Wall St. Rank hold DCOY as of Q2 2024.
- Vanguard Group reported no remaining Decoy Therapeutics position as of Q2 2024 after selling out during the quarter.
- Vanguard Group sold 10 Decoy Therapeutics shares in Q2 2024, an estimated $7.7K.
- Vanguard Group first reported a position in Decoy Therapeutics in Q3 2020 and held it in 15 quarters.
- Vanguard Group's Decoy Therapeutics position peaked at $2.1M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2024.
Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.